| Fiscal period | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|
| Period End Date | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 |
|---|
| Revenue | 1,635.25 | 1,610.53 | 1,541.57 | 1,557.67 | 1,542.45 | 1,371.87 | 1,517.56 | 1,472.44 | 1,188.24 | 992.08 |
| Product sales | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Revenues | 1,635.25 | 1,610.53 | 1,541.57 | 1,557.67 | 1,542.45 | 1,371.87 | 1,517.56 | 1,472.44 | 1,188.24 | 992.08 |
| Cost of product revenues | 803.63 | 728.47 | 656.84 | 587.36 | 597.81 | 520.83 | 564.68 | 571.50 | 435.51 | 349.09 |
| Goodwill impairment charge | 511.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible asset amortization | 14.95 | 21.29 | 12.38 | 13.88 | 16.91 | 27.76 | 27.03 | 21.16 | 20.37 | 13.86 |
| Research and development | 98.97 | 115.38 | 104.19 | 101.19 | 93.05 | 77.38 | 79.57 | 78.04 | 63.46 | 58.16 |
| In-process research and development | -- | -- | -- | -- | 0.00 | 0.00 | 64.92 | -- | -- | -- |
| General and Administrative | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, general and administrative | 699.70 | 716.98 | 656.64 | 616.32 | 637.45 | 594.53 | 687.60 | 690.75 | 624.10 | 455.63 |
| Selling and marketing | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Income (Loss) | (493.37) | 28.41 | 111.53 | 238.92 | 197.23 | 151.37 | 93.76 | 111.00 | 44.80 | 115.34 |
| Interest expense | 86.26 | 70.63 | 51.38 | 49.59 | 50.40 | 71.58 | 53.96 | 64.68 | 35.02 | 25.80 |
| Interest income | 18.47 | 20.04 | 17.20 | 11.92 | 6.74 | 9.30 | 10.78 | 2.80 | 0.26 | 0.02 |
| Other income (expense), net | (2.35) | 3.94 | 3.72 | 12.01 | 19.31 | 4.43 | 9.52 | 8.29 | 1.35 | 0.85 |
| Gain on dispositions of product lines | -- | 0.00 | -- | 0.64 | 41.80 | -- | -- | -- | -- | -- |
| Income (loss) before income taxes | (563.50) | (18.24) | 81.07 | 213.89 | 214.68 | 93.52 | 60.10 | 57.40 | 11.39 | 90.41 |
| United States operations | -- | -- | -- | -- | -- | -- | -- | -- | (32.64) | 51.35 |
| Foreign operations | -- | -- | -- | -- | -- | -- | -- | -- | 44.03 | 39.06 |
| Current-State | -- | -- | -- | -- | -- | -- | -- | 1.61 | 1.23 | 2.50 |
| Current- Foreign | -- | -- | -- | -- | -- | -- | -- | 7.06 | 6.07 | 6.11 |
| Deferred- Foreign | -- | -- | -- | -- | -- | -- | -- | 2.07 | (0.08) | (1.32) |
| Deferred:Federal | (36.75) | (27.15) | (19.06) | (11.59) | (12.83) | (5.08) | (10.89) | (7.20) | (66.47) | (3.40) |
| Deferred:State | (6.87) | (4.09) | 0.09 | (2.32) | (3.69) | (1.76) | (0.67) | (3.05) | (0.76) | (1.75) |
| Provision for income taxes | (47.03) | (11.29) | 13.33 | 33.34 | 45.60 | (40.37) | 9.90 | (3.40) | (53.36) | 15.84 |
| Current-Federal | 6.93 | (0.26) | 10.97 | 24.20 | 31.94 | 6.18 | 14.60 | (3.88) | 6.64 | 13.70 |
| Income(Loss) from continuing operations | -- | -- | -- | -- | -- | -- | -- | -- | 64.74 | 74.56 |
| Income (Loss) from discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income (loss) before accounting change | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Extraordinary loss, net of income tax benefit | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (Loss) Available to Common Shareholders | (516.47) | (6.94) | 67.74 | 180.55 | 169.08 | 133.89 | 50.20 | 60.80 | 64.74 | 74.56 |
| Basic net income (loss) per share before extraordinary item and cumulative effec | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| continuing operations ( basic) | -- | -- | -- | -- | -- | -- | -- | -- | 0.84 | 1.00 |
| Income (loss) from discontinued operations ( basic) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Basic net income per share | (6.74) | (0.09) | 0.85 | 2.18 | 2.00 | 1.58 | 0.59 | 0.73 | 0.84 | 1.00 |
| Continuing operations (Diluted) | -- | -- | -- | -- | -- | -- | -- | -- | 0.82 | 0.94 |
| Diluted net income (loss) per share before extraordinary item and cumulative eff | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income (loss) from discontinued operations (Diluted) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Diluted net income per share | (6.74) | (0.09) | 0.84 | 2.16 | 1.98 | 1.57 | 0.58 | 0.72 | 0.82 | 0.94 |
| Weighted Average Shares Outstanding (Basic) | 76.67 | 77.01 | 80.09 | 83.00 | 84.70 | 84.65 | 85.64 | 82.86 | 76.90 | 74.39 |
| Weighted Average Shares Outstanding (Diluted) | 76.67 | 77.01 | 80.34 | 83.52 | 85.49 | 85.23 | 86.49 | 84.00 | 79.12 | 79.19 |